InnoSer is inviting all interested in using midbrain organoids as a platform for Parkinson’s disease drug development to its webinar organized in collaboration with OrganoTherapeutics. The presentation outlining the platform characteristics and use will be given by the CSO of OrganoTherapeutics, Dr. Javier Jarazo. This will be followed by a Q&A session also to address how InnoSer makes this platform available as a service.

Event details: 15 October 2020 | 16:00

Participating in this event is no longer possible. Please contact our team for information on our organoid based services.